| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0092-8674(83)90006-5 |
| P698 | PubMed publication ID | 6871989 |
| P2093 | author name string | Perry RP | |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 647-649 | |
| P577 | publication date | 1983-07-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Consequences of myc invasion of immunoglobulin loci: facts and speculation | |
| P478 | volume | 33 |
| Q41581777 | A human T-cell antigen receptor beta chain gene maps to chromosome 7 |
| Q39551401 | A model to account for the effects of oncogenes, TPA, and retinoic acid on the regulation of genes involved in metastasis |
| Q33932184 | Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives |
| Q36953589 | Acquisition of an intracisternal A-particle element by a translocated c-myc gene in a murine plasma cell tumor |
| Q37690084 | Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma |
| Q41363072 | Amplification and altered expression of the c-myc oncogene in A-MuLV-transformed fibroblasts |
| Q34339751 | Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line |
| Q39831901 | Analysis of gene expression during hematopoiesis: present and future applications |
| Q44878104 | B-Ly1 cells: immortal Ly-1+ B lymphocyte cell lines spontaneously arising in murine splenic cultures |
| Q53520318 | C-myc expression and transformed phenotypes in hybrid clones between mouse plasmacytoma S194 cells and normal spleen cells or fibroblasts |
| Q47606644 | Case of acute lymphoblastic leukemia presenting with t(14;18)/BCL2, t(8;14)/cMYC, and t(1;2)/FCGR2B |
| Q37680879 | Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration |
| Q24615673 | Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene |
| Q41433504 | Characterization of immunoglobulin enhancer deletions in murine plasmacytomas |
| Q33932005 | Chromatin structure of the murine c-myc locus: implications for the regulation of normal and chromosomally translocated genes. |
| Q33931387 | Chromosome translocations clustered 5' of the murine c-myc gene qualitatively affect promoter usage: implications for the site of normal c-myc regulation |
| Q59315489 | Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11) |
| Q48377324 | Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. |
| Q37675766 | Comparison of chemically induced and spontaneous murine thymic lymphomas in RF and AKR mice: differential expression of c-myc and c-myb |
| Q41505766 | Deregulation of immunoglobulin expression: is this the main cause of Burkitt's lymphoma? |
| Q50421170 | Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis |
| Q37684217 | Differential efficiencies of in vitro translation of mouse c-myc transcripts differing in the 5' untranslated region |
| Q36353506 | Elevated myc expression and c-myc amplification in spontaneously occurring B lymphoid cell lines |
| Q39494403 | Evolution of tumours and the impact of molecular oncology |
| Q54613997 | Further implications of the territorial effects of genes: chromosomal translocation and oncogene activation. |
| Q45213240 | Generation of adhesive tumor variants: chromosomal changes, reduction in malignancy and increased expression of a distinct membrane glycoprotein |
| Q40174577 | Generation of phenotypic diversity and progression in metastatic tumor cells |
| Q70339238 | Human oncogenes |
| Q40210195 | Identification of reciprocal translocation sites within the c-myc oncogene and immunoglobulin mu locus in a Burkitt lymphoma |
| Q52273529 | Immortalized B lymphocytes produce B-cell growth factor. |
| Q35593384 | Induction of c-myc expression in human B lymphocytes by B-cell growth factor and anti-immunoglobulin |
| Q54471667 | Is myeloma really a monoclonal disease? |
| Q37401701 | Localization of a lymphocyte-specific protein tyrosine kinase gene (lck) at a site of frequent chromosomal abnormalities in human lymphomas |
| Q41586164 | Mechanism of activation of the mouse c-mos oncogene by the LTR of an intracisternal A-particle gene |
| Q40177205 | Methylation, expression and chromosomal position of genes in mammals |
| Q53544585 | Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations. |
| Q36903525 | Nonproductive kappa immunoglobulin genes: recombinational abnormalities and other lesions affecting transcription, RNA processing, turnover, and translation |
| Q48388335 | Nucleotide sequence comparison of normal and translocated murine c-myc genes |
| Q40170416 | Oncogenes: Clues to carcinogenesis |
| Q59085650 | Oncogenesis: Paradox and paradigm: the message and meaning of myc |
| Q36586574 | Ordered rearrangement of immunoglobulin heavy chain variable region segments |
| Q36849846 | P21 v-ras inhibits induction of c-myc and c-fos expression by platelet-derived growth factor |
| Q24614782 | Proviral integration site Mis-1 in rat thymomas corresponds to the pvt-1 translocation breakpoint in murine plasmacytomas |
| Q43470081 | Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks |
| Q40670672 | Rearrangement at the 5' end of amplified c-myc in human COLO 320 cells is associated with abnormal transcription |
| Q33934166 | Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. |
| Q72405715 | Sex- and tissue-specific, but hormonally independent, demethylation at the 3'-end of Xenopus vitellogenin gene B1 |
| Q40191686 | Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants |
| Q36945187 | Structure and Expression of the Oncogene c-myc in Fresh Tumor Material from Patients with Hematopoietic Malignancies |
| Q36896486 | Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells |
| Q39831575 | The T cell antigen receptor |
| Q53545013 | The human T-cell receptor alpha-chain gene maps to chromosome 14. |
| Q37580071 | The protein encoded by the human proto-oncogene c-myc |
| Q40419300 | Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression |
| Q37566467 | Translocation and rearrangement of c-myc into immunoglobulin alpha heavy chain locus in primary cells from acute lymphocytic leukemia |
| Q45041223 | Transposition and amplification of oncogene-related sequences in human neuroblastomas |
| Q54476622 | Tumor progression, oncogenes and the evolution of metastatic phenotypic diversity. |
| Q57338725 | Variant (6 ; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin κ gene but far from the myc oncogene |
| Q24555810 | Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene |
Search more.